Evidence map›Paper›PMID 28797110›Full record

ArticlePloS one2017

GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer.

Shimeng Cheng, Qiqi Mao, Yabing Dong, Jie Ren, Lina Su, Jianlan Liu, Qingmei Liu, Jing Zhou, Xiaolu Ye, Shudan Zheng and 1 more

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. [GNB2L1 gene expression and clinical value in hepatocellular carcinoma based on bioinformatics].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022
    Article
  8. Review
  9. Article
  10. Role ofPhysiological reviews · 2021
    Review
  11. Review
  12. Article
  13. Functional Analysis ofFrontiers in oncology · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Shimeng ChengDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Qiqi MaoDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Yabing DongDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Jie RenDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Lina SuDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Jianlan LiuDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Qingmei LiuDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Jing ZhouDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Xiaolu YeDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Shudan ZhengDepartment of Physiology, Hainan Medical College, Haikou, China.
Ningwen ZhuDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0003-4224-4188
Fudan University · CNHainan Medical College Hospital · CN

Funding

Adolescents with Major Depression and AUD: Community-Based Integrated TreatmentR01AA020705 · NIAAA · BROWN UNIVERSITY · PI SPIRITO, ANTHONY · 2012 to 2016
$3.3M
NIAAA NIH HHS R01 AA020705
6 · The paper itself

Abstract

GNB2L1 and its O-GlcNAcylation has been reported to play roles in gastric cancer metastasis. However, the roles of GNB2L1 in chemoresistance of gastric cancer has never been determined. In the present study, we found that GNB2L1 was downregulated in chemoresistant patients of gastric cancer, and observed the decrease of GNB2L1 in protein levels instead of mRNA levels in different chemoresistant gastric cancer cell lines. Further we proved that this downregulation of GNB2L1 was resulted from its elevated O-GlcNAcylation catalyzed by OGT in both cell lines and patients. Next, we investigate the function of GNB2L1 and its O-GlcNAcylation on gastric cancer metastasis during chemoresistance, and confirmed Ser124 as the major O-GlcNAcylation site on GNB2L1 that regulated its function on metastasis. Furthermore, our data demonstrated that GNB2L1 modulated EMT via regulating the translation of EMT-related proteins in the process of chemoresistance. In summary, this study indicated that GNB2L1 and its O-GlcNAcylation regulated metastasis via modulating the translation of EMT-related proteins in the chemoresistance of gastric cancer.

Indexed as

Drug Resistance, NeoplasmEpithelial-Mesenchymal TransitionProtein Processing, Post-TranslationalAcetylglucosamineCell Line, TumorCell MovementGlycosylationGTP-Binding ProteinsHumansN-AcetylglucosaminyltransferasesNeoplasm ProteinsReceptors, Cell SurfaceReceptors for Activated C KinaseStomach NeoplasmsAcetylglucosamineGTP-Binding ProteinsN-AcetylglucosaminyltransferasesNeoplasm ProteinsRACK1 protein, humanReceptors, Cell SurfaceReceptors for Activated C Kinase

Identifiers

PMID28797110
PMCPMC5552253
OpenAlexW2743464703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.